Skip to content

NoRge_

Johns Hopkins University

On October 4th, 2023. Dr. Lampe presented a seminar in the Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore (https://www.hopkinsmedicine.org/pharmacology-molecular-sciences), entitled: “Cytochrome P450 enzymes in the’pathobiome’: how Pseudomonas aeruginosa evades antibiotics through drug metabolism”

Rocky Mountain Discussion group

On September 29th, 2023. Dr. Lampe hosted the 2023 Annual Meeting of the Rocky Mountain Discussion group, with some fantastic speakers!

Focus on Pharmacology

On September 25th, 2023. Dr. Lampe presented a talk at the ASPET Focus on Pharmacology series: Advances in Drug Metabolism, hosted by DMDD, entitled “CYP3A7’s Role in Parturition and Adverse Drug-hormone Interactions” (you can watch the recording here: https://youtu.be/AinWY0ef16A).

Lampe lab BBQ

Welcoming to 2 new lab members, Julieta Torres (Undergraduate student) and Abhinav Pentyala (Master student).

Drug Metabolism GRS – 2023

On July 8-9, 2023. Hannah Work presented a poster on her research work on HCV inhibitors.

ASPET 2023

On May 18-21, 2023. The LAMPE Lab presented several of their research works in poster or talk format.

International Conferences on Cytochrome P450

In May 2023, Dr. Lampe was asked by Prof. Fred Guengerich to organize the 2027 International Conference on Cytochrome P450 (http://www.p450meetings.com/future/), which will be held right here in Denver, Colorado!

ISSX

In April 2023, Dr. Lampe was invited to join the International Society for the Study of Xenobiotics (ISSX: https://www.issx.org/) Biotransformation, Mechanisms, and Pathways Focus Group steering committee. Congratulations, Dr. Lampe!

Dalhousie University

On February 7th, 2023. Dr. Lampe gave a presentation in the Department of Pharmacology at Dalhousie University (https://medicine.dal.ca/departments/department-sites/pharmacology.html) in Newfoundland, Canada entitled, “Discovery and development of natural product and PROTAC-based inhibitors of the SARS-CoV-2 main protease, Mpro”.